Mei‐Ling Nan

698 total citations
6 papers, 454 citations indexed

About

Mei‐Ling Nan is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mei‐Ling Nan has authored 6 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Mei‐Ling Nan's work include interferon and immune responses (6 papers), Inflammasome and immune disorders (4 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Mei‐Ling Nan is often cited by papers focused on interferon and immune responses (6 papers), Inflammasome and immune disorders (4 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Mei‐Ling Nan collaborates with scholars based in China, Nigeria and United States. Mei‐Ling Nan's co-authors include Pei‐Hui Wang, Jian Deng, Chengjiang Gao, Yi Zheng, Lulu Han, Meng‐Wei Zhuang, Xuejing Zhang, Jing Zhang, Yang Xiao and Jing Zhang and has published in prestigious journals such as Signal Transduction and Targeted Therapy, Advances in experimental medicine and biology and Journal of Medical Virology.

In The Last Decade

Mei‐Ling Nan

6 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Ling Nan China 6 285 246 180 59 56 6 454
Laura Martin‐Sancho United States 8 227 0.8× 164 0.7× 155 0.9× 81 1.4× 51 0.9× 16 445
Rayhane Nchioua Germany 8 150 0.5× 159 0.6× 105 0.6× 64 1.1× 21 0.4× 16 338
Maximilian Hirschenberger Germany 7 439 1.5× 147 0.6× 229 1.3× 46 0.8× 77 1.4× 7 615
Ruiyi Ma China 3 599 2.1× 330 1.3× 188 1.0× 73 1.2× 129 2.3× 8 777
Avery Peace United States 3 222 0.8× 84 0.3× 162 0.9× 57 1.0× 21 0.4× 5 358
Ansgar F. Stenzel Germany 2 219 0.8× 82 0.3× 160 0.9× 56 0.9× 21 0.4× 2 351
Yuan Pu United States 6 186 0.7× 142 0.6× 119 0.7× 57 1.0× 50 0.9× 12 364
Devin Kenney United States 8 199 0.7× 171 0.7× 144 0.8× 33 0.6× 26 0.5× 16 424
Markus Mukenhirn Germany 7 221 0.8× 104 0.4× 88 0.5× 40 0.7× 42 0.8× 9 367

Countries citing papers authored by Mei‐Ling Nan

Since Specialization
Citations

This map shows the geographic impact of Mei‐Ling Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ling Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ling Nan more than expected).

Fields of papers citing papers by Mei‐Ling Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Ling Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ling Nan. The network helps show where Mei‐Ling Nan may publish in the future.

Co-authorship network of co-authors of Mei‐Ling Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Ling Nan. A scholar is included among the top collaborators of Mei‐Ling Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Ling Nan. Mei‐Ling Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Deng, Jian, Yang Xiao, Mei‐Ling Nan, et al.. (2023). SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways. Journal of Medical Virology. 95(4). e28680–e28680. 20 indexed citations
2.
Deng, Jian, Yi Zheng, Mei‐Ling Nan, et al.. (2023). SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways. Journal of Medical Virology. 95(3). e28561–e28561. 25 indexed citations
3.
Zheng, Yi, Jian Deng, Lulu Han, et al.. (2022). SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Signal Transduction and Targeted Therapy. 7(1). 22–22. 119 indexed citations
4.
Han, Lulu, Yi Zheng, Jian Deng, et al.. (2022). SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy. Journal of Medical Virology. 94(11). 5174–5188. 66 indexed citations
5.
Han, Lulu, Meng‐Wei Zhuang, Jian Deng, et al.. (2021). SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways. Journal of Medical Virology. 93(9). 5376–5389. 182 indexed citations
6.
Zhu, Yun, Jian Deng, Mei‐Ling Nan, et al.. (2019). The Interplay Between Pattern Recognition Receptors and Autophagy in Inflammation. Advances in experimental medicine and biology. 1209. 79–108. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026